A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee

NCT01366014 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: ARRY-371797, p38 inhibitor; oral
DRUG: Oxycodone hydrochloride (HCl) extended release (ER), opioid agonist; oral
DRUG: Placebo; oral

Sponsor

Pfizer